{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T08:18:45Z","timestamp":1792657125857,"version":"4.5.0"},"reference-count":131,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2010,2,1]],"date-time":"2010-02-01T00:00:00Z","timestamp":1264982400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2010,2,1]],"date-time":"2010-02-01T00:00:00Z","timestamp":1264982400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jaad.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the American Academy of Dermatology"],"published-print":{"date-parts":[[2010,2]]},"DOI":"10.1016\/j.jaad.2009.10.031","type":"journal-article","created":{"date-parts":[[2010,1,15]],"date-time":"2010-01-15T00:58:20Z","timestamp":1263517100000},"page":"191-202","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":242,"title":["Alopecia areata update"],"prefix":"10.1016","volume":"62","author":[{"given":"Abdullah","family":"Alkhalifah","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adel","family":"Alsantali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eddy","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin J.","family":"McElwee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jerry","family":"Shapiro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaad.2009.10.031_bib1","article-title":"Interventions for alopecia areata","volume":"2","author":"Delamere","year":"2008","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.jaad.2009.10.031_bib2","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1016\/j.jaad.2003.09.032","article-title":"Alopecia areata investigational assessment guidelines\u2014part II. National Alopecia Areata Foundation","volume":"51","author":"Olsen","year":"2004","journal-title":"J\u00a0Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2009.10.031_bib3","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.sder.2008.12.002","article-title":"Alopecia areata: evidence-based treatments","volume":"28","author":"Garg","year":"2009","journal-title":"Semin Cutan Med Surg"},{"key":"10.1016\/j.jaad.2009.10.031_bib4","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1111\/j.1365-2133.1973.tb06672.x","article-title":"Intralesional treatment of alopecia areata with triamcinolone acetonide by jet injector","volume":"88","author":"Abell","year":"1973","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaad.2009.10.031_bib5","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1111\/j.1365-2133.1971.tb07230.x","article-title":"A comparison of intra-lesional triamcinolone hexacetonide and triamcinolone acetonide in alopecia areata","volume":"85","author":"Porter","year":"1971","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaad.2009.10.031_bib6","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1016\/j.bbrc.2007.03.065","article-title":"Effect of thioredoxin reductase 1 on glucocorticoid receptor activity in human outer root sheath cells","volume":"356","author":"Sohn","year":"2007","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.jaad.2009.10.031_bib7","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.1001\/archderm.136.10.1276","article-title":"Randomized double-blind placebo-controlled trial in the treatment of alopecia areata with 0.25% desoximetasone cream","volume":"136","author":"Charuwichitratana","year":"2000","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.jaad.2009.10.031_bib8","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1046\/j.1365-4362.2003.01862.x","article-title":"Efficacy of betamethasone valerate foam formulation in comparison with betamethasone dipropionate lotion in the treatment of mild-to-moderate alopecia areata: a multicenter, prospective, randomized, controlled, investigator-blinded trial","volume":"42","author":"Mancuso","year":"2003","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.jaad.2009.10.031_bib9","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1067\/mjd.2003.423","article-title":"Clobetasol propionate 0.05% under occlusion in the treatment of alopecia totalis\/universalis","volume":"49","author":"Tosti","year":"2003","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2009.10.031_bib10","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1111\/j.1468-3083.2006.01781.x","article-title":"Efficacy and safety of a new clobetasol propionate 0.05% foam in alopecia areata: a randomized, double-blind placebo-controlled trial","volume":"20","author":"Tosti","year":"2006","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.jaad.2009.10.031_bib11","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1159\/000252466","article-title":"Assay of 0.2 percent fluocinolone acetonide cream for alopecia areata and totalis. Efficacy and side effects including histologic study of the ensuing localized acneform response","volume":"141","author":"Pascher","year":"1970","journal-title":"Dermatologica"},{"key":"10.1016\/j.jaad.2009.10.031_bib12","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1111\/1523-1747.ep12261084","article-title":"Minoxidil stimulates cutaneous blood flow in human balding scalps: pharmacodynamics measured by laser Doppler velocimetry and photopulse plethysmography","volume":"82","author":"Wester","year":"1984","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.jaad.2009.10.031_bib13","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1111\/j.1365-2133.1987.tb07505.x","article-title":"Alterations in scalp blood flow after the epicutaneous application of 3% minoxidil and 0.1% hexyl nicotinate in alopecia","volume":"117","author":"Bunker","year":"1987","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaad.2009.10.031_bib14","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1046\/j.1365-2133.1998.02115.x","article-title":"Minoxidil upregulates the expression of vascular endothelial growth factor in human hair dermal papilla cells","volume":"138","author":"Lachgar","year":"1998","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaad.2009.10.031_bib15","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1016\/S0190-9622(87)70084-X","article-title":"Action of topical minoxidil in the bald stump-tailed macaque","volume":"16","author":"Uno","year":"1987","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2009.10.031_bib16","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1111\/j.1346-8138.1990.tb01641.x","article-title":"The effect of topical minoxidil on hair follicular cycles of rats","volume":"17","author":"Mori","year":"1990","journal-title":"J Dermatol"},{"key":"10.1016\/j.jaad.2009.10.031_bib17","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1111\/1523-1747.ep12499788","article-title":"Potassium channel conductance: a mechanism affecting hair growth both in vitro and in vivo","volume":"98","author":"Buhl","year":"1992","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.jaad.2009.10.031_bib18","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1111\/j.1365-2133.2004.05785.x","article-title":"Minoxidil: mechanisms of action on hair growth","volume":"150","author":"Messenger","year":"2004","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaad.2009.10.031_bib19","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1111\/j.1365-4362.1985.tb05774.x","article-title":"In vitro suppression of human lymphocyte activity by minoxidil","volume":"24","author":"Galbraith","year":"1985","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.jaad.2009.10.031_bib20","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1016\/S0190-9622(87)70083-8","article-title":"Potential mechanisms of minoxidil-induced hair growth in alopecia areata","volume":"16","author":"Fiedler-Weiss","year":"1987","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2009.10.031_bib21","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1016\/S0190-9622(87)70095-4","article-title":"Double-blind, placebo-controlled evaluation of topical minoxidil in extensive alopecia areata","volume":"16","author":"Price","year":"1987","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2009.10.031_bib22","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1016\/S0190-9622(87)80003-8","article-title":"Topical minoxidil solution (1% and 5%) in the treatment of alopecia areata","volume":"16","author":"Fiedler-Weiss","year":"1987","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2009.10.031_bib23","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1016\/S0190-9622(87)70096-6","article-title":"Topical minoxidil (3%) in extensive alopecia areata, including long-term efficacy","volume":"16","author":"Price","year":"1987","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2009.10.031_bib24","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1067\/mjd.2002.124088","article-title":"A randomized clinical trial of 5% topical minoxidil versus 2% topical minoxidil and placebo in the treatment of androgenetic alopecia in men","volume":"47","author":"Olsen","year":"2002","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2009.10.031_bib25","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1016\/j.jaad.2007.04.012","article-title":"A multicenter, randomized, placebo-controlled, double-blind clinical trial of a novel formulation of 5% minoxidil topical foam versus placebo in the treatment of androgenetic alopecia in men","volume":"57","author":"Olsen","year":"2007","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2009.10.031_bib26","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1016\/j.jaad.2003.06.014","article-title":"A randomized, placebo-controlled trial of 5% and 2% topical minoxidil solutions in the treatment of female pattern hair loss","volume":"50","author":"Lucky","year":"2004","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2009.10.031_bib27","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1001\/archderm.1979.04010100058026","article-title":"Treatment of alopecia areata by anthralin-induced dermatitis","volume":"115","author":"Schmoeckel","year":"1979","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.jaad.2009.10.031_bib28","doi-asserted-by":"crossref","first-page":"1491","DOI":"10.1001\/archderm.1987.01660350091020","article-title":"Evaluation of anthralin in the\u00a0treatment of alopecia areata","volume":"123","author":"Fiedler-Weiss","year":"1987","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.jaad.2009.10.031_bib29","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1111\/j.0906-6705.2004.00098.x","article-title":"Restoration of hair growth in mice with an alopecia areata-like disease using topical anthralin","volume":"13","author":"Tang","year":"2004","journal-title":"Exp Dermatol"},{"key":"10.1016\/j.jaad.2009.10.031_bib30","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1046\/j.1365-2133.2003.05535.x","article-title":"Guidelines for the management of alopecia areata","volume":"149","author":"MacDonald Hull","year":"2003","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaad.2009.10.031_bib31","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1001\/archderm.1990.01670300056006","article-title":"Treatment-resistant alopecia areata. Response to combination therapy with minoxidil plus anthralin","volume":"126","author":"Fiedler","year":"1990","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.jaad.2009.10.031_bib32","doi-asserted-by":"crossref","first-page":"403","DOI":"10.2165\/00128071-200506060-00007","article-title":"Comparison of azelaic acid and anthralin for the therapy of patchy alopecia areata: a pilot study","volume":"6","author":"Sasmaz","year":"2005","journal-title":"Am J Clin Dermatol"},{"key":"10.1016\/j.jaad.2009.10.031_bib33","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1007\/BF00293811","article-title":"Mutagenic and cell transforming activities of 1-chlor-2,4-dinitrobenzene (DNCB) and squaric-acid-dibutylester (SADBE)","volume":"45","author":"Strobel","year":"1980","journal-title":"Arch Toxicol"},{"key":"10.1016\/j.jaad.2009.10.031_bib34","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/0165-1218(80)90124-X","article-title":"1-chloro-2,4-dinitrobenzene depletes glutathione in rat skin and is mutagenic in Salmonella typhimurium","volume":"77","author":"Summer","year":"1980","journal-title":"Mutat Res"},{"key":"10.1016\/j.jaad.2009.10.031_bib35","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1016\/S0190-9622(84)80456-9","article-title":"Diphenylcyclopropenone: examination for potential contaminants, mechanisms of sensitization, and photochemical stability","volume":"11","author":"Wilkerson","year":"1984","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2009.10.031_bib36","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/S0190-9622(85)70164-8","article-title":"Squaric acid and esters: analysis for contaminants and stability in solvents","volume":"13","author":"Wilkerson","year":"1985","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2009.10.031_bib37","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/0190-9622(91)70032-W","article-title":"Prognostic factors in the treatment of alopecia areata with diphenylcyclopropenone","volume":"24","author":"van der Steen","year":"1991","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2009.10.031_bib38","first-page":"1063","article-title":"Predictive model for immunotherapy of alopecia areata with diphencyprone","volume":"137","author":"Wiseman","year":"2001","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.jaad.2009.10.031_bib39","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1159\/000246337","article-title":"Topical immunotherapy in alopecia areata: anamnestic and clinical criteria of prognostic significance","volume":"192","author":"Weise","year":"1996","journal-title":"Dermatology"},{"key":"10.1016\/j.jaad.2009.10.031_bib40","first-page":"397","article-title":"Diphenylcyclopropenone (diphencyprone, DPCP) in the treatment of chronic severe alopecia areata (AA)","volume":"35","author":"Galadari","year":"2003","journal-title":"Eur Ann Allergy Clin Immunol"},{"key":"10.1016\/j.jaad.2009.10.031_bib41","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1046\/j.1365-2133.1996.119854.x","article-title":"Topical diphencyprone for alopecia areata: evaluation of 48 cases after 30 months' follow-up","volume":"134","author":"Gordon","year":"1996","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaad.2009.10.031_bib42","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1016\/j.jaad.2006.05.008","article-title":"Alopecia areata: a long term follow-up study of 191 patients","volume":"55","author":"Tosti","year":"2006","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2009.10.031_bib43","first-page":"11","article-title":"Genetic susceptibility and severity of alopecia areata in human and animal models","volume":"11","author":"McElwee","year":"2001","journal-title":"Eur J Dermatol"},{"key":"10.1016\/j.jaad.2009.10.031_bib44","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1111\/j.1365-2133.1991.tb00643.x","article-title":"Alopecia areata and topical sensitizers: allergic response is necessary but irritation is not","volume":"124","author":"Orecchia","year":"1991","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaad.2009.10.031_bib45","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1111\/j.1525-1470.1994.tb00078.x","article-title":"Treatment of severe alopecia areata with squaric acid dibutylester in pediatric patients","volume":"11","author":"Orecchia","year":"1994","journal-title":"Pediatr Dermatol"},{"key":"10.1016\/j.jaad.2009.10.031_bib46","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1080\/09546630410023601","article-title":"Topical immunomodulator therapy with squaric acid dibutylester (SADBE) is effective treatment for severe alopecia areata (AA): results of an open-label, paired-comparison, clinical trial","volume":"16","author":"Dall'oglio","year":"2005","journal-title":"J Dermatolog Treat"},{"key":"10.1016\/j.jaad.2009.10.031_bib47","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/1471-5945-5-6","article-title":"Topical immunotherapy of severe alopecia areata with diphenylcyclopropenone (DPCP): experience in an Iranian population","volume":"5","author":"Aghaei","year":"2005","journal-title":"BMC Dermatol"},{"key":"10.1016\/j.jaad.2009.10.031_bib48","first-page":"48","article-title":"Topical immunotherapy with diphenylcyclopropenone in the treatment of chronic extensive alopecia areata","volume":"32","author":"Sotiriadis","year":"2007","journal-title":"Clin Exp Dermatol"},{"key":"10.1016\/j.jaad.2009.10.031_bib49","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1034\/j.1600-0536.2002.4705102.x","article-title":"Urticaria after topical immunotherapy with diphenylcyclopropenone","volume":"47","author":"Francomano","year":"2002","journal-title":"Contact Dermatitis"},{"key":"10.1016\/j.jaad.2009.10.031_bib50","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/S0190-9622(99)70540-2","article-title":"Severe urticarial reaction to diphenylcyclopropenone therapy for alopecia areata","volume":"40","author":"Alam","year":"1999","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2009.10.031_bib51","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1111\/j.1600-0536.1989.tb04737.x","article-title":"Contact urticaria during topical immunotherapy","volume":"21","author":"Tosti","year":"1989","journal-title":"Contact Dermatitis"},{"key":"10.1016\/j.jaad.2009.10.031_bib52","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1159\/000247976","article-title":"Erythema multiforme\u2013like eruptions: a rare side effect of topical immunotherapy with diphenylcyclopropenone","volume":"180","author":"Perret","year":"1990","journal-title":"Dermatologica"},{"key":"10.1016\/j.jaad.2009.10.031_bib53","doi-asserted-by":"crossref","first-page":"276","DOI":"10.47102\/annals-acadmedsg.V38N3p276","article-title":"Vitiligo as an adverse reaction to topical diphencyprone","volume":"38","author":"Pan","year":"2009","journal-title":"Ann Acad Med Singapore"},{"key":"10.1016\/j.jaad.2009.10.031_bib54","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1111\/j.1365-2133.1995.tb02692.x","article-title":"Vitiligo complicating diphencyprone sensitization therapy for alopecia universalis","volume":"133","author":"Henderson","year":"1995","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaad.2009.10.031_bib55","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1016\/S0190-9622(98)70048-9","article-title":"Efficacy of topical sensitizers in the treatment of alopecia areata","volume":"39","author":"Rokhsar","year":"1998","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2009.10.031_bib56","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1007\/BF00416931","article-title":"Antigenic competition as a therapeutic concept for alopecia areata","volume":"267","author":"Happle","year":"1980","journal-title":"Arch Dermatol Res"},{"key":"10.1016\/j.jaad.2009.10.031_bib57","first-page":"537","article-title":"Diphenylcyclopropenone treatment of alopecia areata induces apoptosis of perifollicular lymphocytes","volume":"16","author":"Herbst","year":"2006","journal-title":"Eur J Dermatol"},{"key":"10.1016\/j.jaad.2009.10.031_bib58","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1007\/BF00412926","article-title":"Topical immunotherapy changes the composition of the peribulbar infiltrate in alopecia areata","volume":"278","author":"Happle","year":"1986","journal-title":"Arch Dermatol Res"},{"key":"10.1016\/j.jaad.2009.10.031_bib59","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1007\/s00403-007-0759-4","article-title":"Changes in distribution pattern of CD8 lymphocytes in the scalp in alopecia areata during treatment with diphencyprone","volume":"299","author":"Wasylyszyn","year":"2007","journal-title":"Arch Dermatol Res"},{"key":"10.1016\/j.jaad.2009.10.031_bib60","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1111\/1523-1747.ep12395722","article-title":"Cytokine mRNA levels in Alopecia areata before and after treatment with the contact allergen diphenylcyclopropenone","volume":"103","author":"Hoffmann","year":"1994","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.jaad.2009.10.031_bib61","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1016\/S0190-9622(98)70009-X","article-title":"Pulse methylprednisolone therapy for severe alopecia areata: an open prospective study of 45 patients","volume":"39","author":"Friedli","year":"1998","journal-title":"J\u00a0Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2009.10.031_bib62","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/j.jaad.2004.10.873","article-title":"Placebo-controlled oral pulse prednisolone therapy in alopecia areata","volume":"52","author":"Kar","year":"2005","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2009.10.031_bib63","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.1001\/archderm.1976.01630350025006","article-title":"Prednisone therapy for alopecia areata. A follow-up report","volume":"112","author":"Winter","year":"1976","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.jaad.2009.10.031_bib64","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1111\/j.1365-4362.1996.tb03281.x","article-title":"Pulsed administration of corticosteroids in the treatment of alopecia areata","volume":"35","author":"Sharma","year":"1996","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.jaad.2009.10.031_bib65","doi-asserted-by":"crossref","first-page":"1467","DOI":"10.1001\/archderm.1992.01680210045005","article-title":"Systemic steroids with or without 2% topical minoxidil in the treatment of alopecia areata","volume":"128","author":"Olsen","year":"1992","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.jaad.2009.10.031_bib66","doi-asserted-by":"crossref","first-page":"493","DOI":"10.2340\/000155555493496","article-title":"Large doses of glucocorticoid in the treatment of alopecia areata","volume":"55","author":"Burton","year":"1975","journal-title":"Acta Derm Venereol"},{"key":"10.1016\/j.jaad.2009.10.031_bib67","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1111\/j.1346-8138.1999.tb02049.x","article-title":"Twice weekly 5 mg dexamethasone oral pulse in the treatment of extensive alopecia areata","volume":"26","author":"Sharma","year":"1999","journal-title":"J Dermatol"},{"key":"10.1016\/j.jaad.2009.10.031_bib68","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1159\/000092287","article-title":"A comparison of the efficacy, relapse rate and side effects among three modalities of systemic corticosteroid therapy for alopecia areata","volume":"212","author":"Kurosawa","year":"2006","journal-title":"Dermatology"},{"key":"10.1016\/j.jaad.2009.10.031_bib69","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/S0733-8635(05)70010-3","article-title":"The risks of systemic corticosteroid use","volume":"16","author":"Lester","year":"1998","journal-title":"Dermatol Clin"},{"key":"10.1016\/j.jaad.2009.10.031_bib70","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1111\/j.1365-2133.1995.tb06925.x","article-title":"PUVA treatment of alopecia areata partialis, totalis and universalis: audit of 10 years' experience at St John's Institute of Dermatology","volume":"133","author":"Taylor","year":"1995","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaad.2009.10.031_bib71","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1111\/j.1468-3083.2005.01226.x","article-title":"Alopecia areata treatment with a phototoxic dose of UVA and topical 8-methoxypsoralen","volume":"19","author":"Mohamed","year":"2005","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.jaad.2009.10.031_bib72","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1111\/j.1365-2133.1993.tb03309.x","article-title":"PUVA treatment for alopecia areata\u2014does it work? A retrospective review of 102 cases","volume":"129","author":"Healy","year":"1993","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaad.2009.10.031_bib73","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1016\/j.jaad.2004.05.026","article-title":"308-nm excimer laser therapy in alopecia areata","volume":"51","author":"Zakaria","year":"2004","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2009.10.031_bib74","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1111\/j.1610-0387.2005.05710.x","article-title":"Excimer laser therapy of alopecia areata\u2014side-by-side evaluation of a representative area [in German]","volume":"3","author":"Raulin","year":"2005","journal-title":"J Dtsch Dermatol Ges"},{"key":"10.1016\/j.jaad.2009.10.031_bib75","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1002\/lsm.20002","article-title":"Treatment of alopecia areata with the 308-nm xenon chloride excimer laser: case report of two successful treatments with the excimer laser","volume":"34","author":"Gundogan","year":"2004","journal-title":"Lasers Surg Med"},{"key":"10.1016\/j.jaad.2009.10.031_bib76","doi-asserted-by":"crossref","first-page":"1483","DOI":"10.1097\/00042728-200712000-00011","article-title":"308-nm excimer laser for the treatment of alopecia areata","volume":"33","author":"Al-Mutairi","year":"2007","journal-title":"Dermatol Surg"},{"key":"10.1016\/j.jaad.2009.10.031_bib77","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1046\/j.1365-4362.2003.01968.x","article-title":"Linear polarized infrared irradiation using Super Lizer is an effective treatment for multiple-type alopecia areata","volume":"42","author":"Yamazaki","year":"2003","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.jaad.2009.10.031_bib78","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1111\/j.1524-4725.2009.01120.x","article-title":"Infrared irradiation as an adjuvant therapy in recalcitrant alopecia areata","volume":"35","author":"Tzung","year":"2009","journal-title":"Dermatol Surg"},{"key":"10.1016\/j.jaad.2009.10.031_bib79","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.1046\/j.1365-2133.2000.03783.x","article-title":"Topical photodynamic therapy with 5-aminolaevulinic acid does not induce hair regrowth in patients with extensive alopecia areata","volume":"143","author":"Bissonnette","year":"2000","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaad.2009.10.031_bib80","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1111\/j.1365-2230.2008.02712.x","article-title":"Failure to treat alopecia areata with photodynamic therapy","volume":"33","author":"Fern\u00e1ndez-Guarino","year":"2008","journal-title":"Clin Exp Dermatol"},{"key":"10.1016\/j.jaad.2009.10.031_bib81","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/S0190-9622(97)70342-6","article-title":"Systemic cyclosporine and low-dose prednisone in the treatment of chronic severe alopecia areata: a clinical and immunopathologic evaluation","volume":"36","author":"Shapiro","year":"1997","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2009.10.031_bib82","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1080\/09546630701846095","article-title":"Combination therapy of cyclosporine and methylprednisolone on severe alopecia areata","volume":"19","author":"Kim","year":"2008","journal-title":"J Dermatolog Treat"},{"issue":"5 suppl. 1","key":"10.1016\/j.jaad.2009.10.031_bib83","doi-asserted-by":"crossref","first-page":"S252","DOI":"10.1016\/j.jaad.2005.03.005","article-title":"Alopecia areata presenting in 2 kidney-pancreas transplant recipients taking cyclosporine","volume":"53","author":"Phillips","year":"2005","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2009.10.031_bib84","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1111\/j.1440-0960.1996.tb01066.x","article-title":"Alopecia areata in a renal transplant recipient on cyclosporin","volume":"37","author":"Dyall-Smith","year":"1996","journal-title":"Australas J Dermatol"},{"key":"10.1016\/j.jaad.2009.10.031_bib85","first-page":"415","article-title":"Multifocal alopecia areata during systemic cyclosporine A therapy","volume":"198","author":"Cerottini","year":"1999","journal-title":"Dermatology"},{"key":"10.1016\/j.jaad.2009.10.031_bib86","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1111\/j.1365-2133.1995.tb00742.x","article-title":"Alopecia areata arising in patients receiving cyclosporin immunosuppression","volume":"132","author":"Davies","year":"1995","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaad.2009.10.031_bib87","first-page":"252","article-title":"Topical cyclosporin A in alopecia areata","volume":"69","author":"Gilhar","year":"1989","journal-title":"Acta Derm Venereol"},{"key":"10.1016\/j.jaad.2009.10.031_bib88","first-page":"507","article-title":"Treatment of severe alopecia areata with topical applications of cyclosporin A [in French]","volume":"114","author":"Mauduit","year":"1987","journal-title":"Ann Dermatol Venereol"},{"key":"10.1016\/j.jaad.2009.10.031_bib89","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1046\/j.1468-3083.2000.00097-14.x","article-title":"Treatment of alopecia areata in the DEBR model using cyclosporin A lipid vesicles","volume":"14","author":"Verma","year":"2004","journal-title":"Eur J Dermatol"},{"key":"10.1016\/j.jaad.2009.10.031_bib90","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1016\/j.jaad.2005.09.010","article-title":"The use of methotrexate alone or in combination with low doses of oral corticosteroids in the treatment of alopecia totalis or universalis","volume":"55","author":"Joly","year":"2006","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2009.10.031_bib91","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1016\/j.jaad.2005.03.039","article-title":"Etanercept does not effectively treat moderate to severe alopecia areata: an open-label study","volume":"52","author":"Strober","year":"2005","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2009.10.031_bib92","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/j.jaad.2007.10.645","article-title":"Subcutaneous efalizumab is not effective in the treatment of alopecia areata","volume":"58","author":"Price","year":"2008","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2009.10.031_bib93","doi-asserted-by":"crossref","first-page":"1654","DOI":"10.1001\/archderm.142.12.1654","article-title":"Development of alopecia areata universalis in a patient receiving adalimumab","volume":"142","author":"Garcia Bartels","year":"2006","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.jaad.2009.10.031_bib94","doi-asserted-by":"crossref","first-page":"48","DOI":"10.2310\/7750.2008.07095","article-title":"Alopecia areata following adalimumab","volume":"13","author":"Kirshen","year":"2009","journal-title":"J Cutan Med Surg"},{"key":"10.1016\/j.jaad.2009.10.031_bib95","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1159\/000162180","article-title":"Alopecia areata universalis during treatment of rheumatoid arthritis with anti-TNF-alpha antibody (adalimumab)","volume":"217","author":"Chaves","year":"2008","journal-title":"Dermatology"},{"key":"10.1016\/j.jaad.2009.10.031_bib96","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1159\/000113945","article-title":"Alopecia areata universalis elicited during treatment with adalimumab","volume":"216","author":"Pelivani","year":"2008","journal-title":"Dermatology"},{"key":"10.1016\/j.jaad.2009.10.031_bib97","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1001\/archderm.140.8.1012-a","article-title":"Alopecia areata in a patient using infliximab: new insights into the role of tumor necrosis factor on human hair follicles","volume":"140","author":"Ettefagh","year":"2004","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.jaad.2009.10.031_bib98","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1159\/000111523","article-title":"Worsening alopecia areata and de novo occurrence of multiple halo nevi in a patient receiving infliximab","volume":"216","author":"Fabre","year":"2008","journal-title":"Dermatology"},{"key":"10.1016\/j.jaad.2009.10.031_bib99","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1001\/archderm.141.6.759","article-title":"Recurrence of alopecia areata in a patient receiving etanercept injections","volume":"141","author":"Posten","year":"2005","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.jaad.2009.10.031_bib100","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1111\/j.1540-9740.2006.05443.x","article-title":"Failure of two TNF-alpha blockers to influence the course of alopecia areata","volume":"5","author":"Abramovits","year":"2006","journal-title":"Skinmed"},{"key":"10.1016\/j.jaad.2009.10.031_bib101","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1080\/09273940802596559","article-title":"Alopecia areata during etanercept therapy","volume":"17","author":"Pan","year":"2009","journal-title":"Ocul Immunol Inflamm"},{"key":"10.1016\/j.jaad.2009.10.031_bib102","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.rdc.2006.12.011","article-title":"Disease-modifying antirheumatic drug use in the elderly rheumatoid arthritis patient","volume":"33","author":"Ranganath","year":"2007","journal-title":"Rheum Dis Clin North Am"},{"key":"10.1016\/j.jaad.2009.10.031_bib103","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1067\/mjd.2002.119671","article-title":"Sulfasalazine for alopecia areata","volume":"46","author":"Ellis","year":"2002","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2009.10.031_bib104","doi-asserted-by":"crossref","first-page":"611","DOI":"10.4103\/0378-6323.45103","article-title":"An uncontrolled, open label study of sulfasalazine in severe alopecia areata","volume":"74","author":"Aghaei","year":"2008","journal-title":"Indian J Dermatol Venereol Leprol"},{"key":"10.1016\/j.jaad.2009.10.031_bib105","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1111\/j.1365-4632.2008.03700.x","article-title":"Treatment of persistent alopecia areata with sulfasalazine","volume":"47","author":"Rashidi","year":"2008","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.jaad.2009.10.031_bib106","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1097\/01.IOP.0000132175.30732.74","article-title":"Trichiasis associated with prostaglandin analog use","volume":"20","author":"Bearden","year":"2004","journal-title":"Ophthal Plast Reconstr Surg"},{"issue":"5 suppl","key":"10.1016\/j.jaad.2009.10.031_bib107","doi-asserted-by":"crossref","first-page":"S149","DOI":"10.1016\/j.jaad.2004.05.002","article-title":"Hypertrichosis of the eyelashes caused by bimatoprost","volume":"51","author":"Tosti","year":"2004","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2009.10.031_bib108","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1016\/S0002-9394(03)01075-4","article-title":"Hypertrichosis of vellus hairs of the malar region after unilateral treatment with bimatoprost","volume":"137","author":"Hart","year":"2004","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.jaad.2009.10.031_bib109","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1111\/j.1468-3083.2004.01020.x","article-title":"Acquired trichomegaly of the eyelashes and hypertrichosis induced by bimatoprost","volume":"18","author":"Herane","year":"2004","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.jaad.2009.10.031_bib110","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1111\/j.0906-6705.2005.00270.x","article-title":"Influence of prostaglandin F2alpha and its analogues on hair regrowth and follicular melanogenesis in a murine model","volume":"14","author":"Sasaki","year":"2005","journal-title":"Exp Dermatol"},{"key":"10.1016\/j.jaad.2009.10.031_bib111","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1016\/j.jaad.2008.08.029","article-title":"Lack of efficacy of topical latanoprost and bimatoprost ophthalmic solutions in promoting eyelash growth in patients with alopecia areata","volume":"60","author":"Roseborough","year":"2009","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2009.10.031_bib112","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1016\/j.jaad.2005.06.031","article-title":"Lack of efficacy of topical latanoprost in the treatment of eyebrow alopecia areata","volume":"53","author":"Ross","year":"2005","journal-title":"J\u00a0Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2009.10.031_bib113","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/j.jaad.2004.05.019","article-title":"Topical tacrolimus in alopecia areata","volume":"52","author":"Price","year":"2005","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2009.10.031_bib114","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1001\/archderm.136.1.124","article-title":"Topical tacrolimus: treatment failure in a patient with alopecia areata","volume":"136","author":"Thiers","year":"2000","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.jaad.2009.10.031_bib115","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1111\/j.1365-2230.2007.02367.x","article-title":"Lack of response of alopecia areata to pimecrolimus cream","volume":"32","author":"Rigopoulos","year":"2007","journal-title":"Clin Exp Dermatol"},{"key":"10.1016\/j.jaad.2009.10.031_bib116","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1046\/j.1365-2133.2002.500210.x","article-title":"Is topical tacrolimus effective in alopecia areata universalis?","volume":"147","author":"Feldmann","year":"2002","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaad.2009.10.031_bib117","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1080\/000155502320624203","article-title":"Topical tacrolimus (FK506): treatment failure in four cases of alopecia universalis","volume":"82","author":"Park","year":"2002","journal-title":"Acta Derm Venereol"},{"key":"10.1016\/j.jaad.2009.10.031_bib118","doi-asserted-by":"crossref","first-page":"592.e1","DOI":"10.1016\/j.jaad.2009.02.037","article-title":"Phase I\/II randomized bilateral half-head comparison of topical bexarotene 1% gel for alopecia areata","volume":"61","author":"Talpur","year":"2009","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2009.10.031_bib119","doi-asserted-by":"crossref","DOI":"10.1111\/j.1468-3083.2009.03243.x","article-title":"Capsaicin vs. clobetasol for the treatment of localized alopecia areata","author":"Ehsani","year":"2009","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.jaad.2009.10.031_bib120","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1111\/j.1087-0024.2004.00835.x","article-title":"Autoimmunity: alopecia areata","volume":"9","author":"Hordinsky","year":"2004","journal-title":"J\u00a0Investig Dermatol Symp Proc"},{"key":"10.1016\/j.jaad.2009.10.031_bib121","article-title":"Treatment of alopecia areata with fractional photothermolysis laser","author":"Yoo","year":"2009","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.jaad.2009.10.031_bib122","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1046\/j.1365-4362.2003.01340.x","article-title":"Alopecia areata: psychiatric comorbidity and adjustment to illness","volume":"42","author":"Ruiz-Doblado","year":"2003","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.jaad.2009.10.031_bib123","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1046\/j.1365-4362.2001.01261-3.x","article-title":"Paroxetine in alopecia areata","volume":"40","author":"Cipriani","year":"2001","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.jaad.2009.10.031_bib124","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.jaad.2005.09.025","article-title":"Hypnotherapeutic management of alopecia areata","volume":"55","author":"Willemsen","year":"2006","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2009.10.031_bib125","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1177\/0961203309106916","article-title":"European Forum on Antiphospholipid Antibodies: research in progress","volume":"18","author":"Meroni","year":"2009","journal-title":"Lupus"},{"key":"10.1016\/j.jaad.2009.10.031_bib126","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1007\/s00403-008-0889-3","article-title":"Prediction and prevention of autoimmune skin disorders","volume":"301","author":"Nancy","year":"2009","journal-title":"Arch Dermatol Res"},{"key":"10.1016\/j.jaad.2009.10.031_bib127","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1136\/ard.2007.069831","article-title":"Vitamin D and autoimmunity: new aetiological and therapeutic considerations","volume":"66","author":"Arnson","year":"2007","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.jaad.2009.10.031_bib128","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1097\/BOR.0b013e32830a991b","article-title":"Vitamin D in systemic lupus erythematosus","volume":"20","author":"Kamen","year":"2008","journal-title":"Curr Opin Rheumatol"},{"key":"10.1016\/j.jaad.2009.10.031_bib129","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.autrev.2007.07.001","article-title":"Vitamin D in rheumatoid arthritis","volume":"7","author":"Cutolo","year":"2007","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.jaad.2009.10.031_bib130","doi-asserted-by":"crossref","first-page":"e18","DOI":"10.1017\/S1462399408000720","article-title":"Therapeutic immunomodulators from nematode parasites","volume":"10","author":"Harnett","year":"2008","journal-title":"Expert Rev Mol Med"},{"key":"10.1016\/j.jaad.2009.10.031_bib131","first-page":"159","article-title":"Ustekinumab in the therapy of chronic plaque psoriasis","volume":"3","author":"O'Neill","year":"2009","journal-title":"Biologics"}],"container-title":["Journal of the American Academy of Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0190962209013620?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0190962209013620?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T22:15:40Z","timestamp":1759270540000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0190962209013620"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,2]]},"references-count":131,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2010,2]]}},"alternative-id":["S0190962209013620"],"URL":"https:\/\/doi.org\/10.1016\/j.jaad.2009.10.031","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.3215956.2900054","asserted-by":"object"}]},"ISSN":["0190-9622"],"issn-type":[{"value":"0190-9622","type":"print"}],"subject":[],"published":{"date-parts":[[2010,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Alopecia areata update","name":"articletitle","label":"Article Title"},{"value":"Journal of the American Academy of Dermatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaad.2009.10.031","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2009 American Academy of Dermatology, Inc. Published by Mosby, Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}